Publications in collaboration with researchers from Hospital de Cabueñes (13)

2024

  1. No gender differences in the 24-month course of non-invasive liver fibrosis markers after DAA therapy in HCV-mono and HCV/HIV-coinfected patients

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. ABNORMAL MORPHOLOGY OF THE SUPERFICIAL TEMPORAL ARTERIES IN THE NOBEL LAUREATE THEODOR MOMMSEN (1817-1903): GIANT CELL ARTERITIS (HORTON'S DISEASE) OR ARTERIOSCLEROSIS? A PALAEOPATHOLOGICAL REASSESSMENT

    Anthropologie (Czech Republic), Vol. 61, Núm. 2, pp. 203-209

2022

  1. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study

    International Journal of Infectious Diseases, Vol. 104, pp. 584-591

2020

  1. Factors associated with sepsis development in 606 Spanish adult patients with cellulitis

    BMC Infectious Diseases, Vol. 20, Núm. 1

2018

  1. Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment

    PLoS ONE, Vol. 13, Núm. 9

2016

  1. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 7, pp. 532-541

2013

  1. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy

    AIDS Research and Human Retroviruses, Vol. 29, Núm. 2, pp. 215-222

  2. Euler's right eye: The dark side of a bright scientist

    Clinical Infectious Diseases

2012

  1. The effect of unsuccessful treatment with peginterferon and ribavirin on the liver fibrosis course of HIV/HCV-coinfected patients

    Current HIV Research, Vol. 10, Núm. 8, pp. 679-687

2011

  1. Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV

    Antiviral Therapy, Vol. 16, Núm. 1, pp. 27-35

2010

  1. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions

    HIV Medicine, Vol. 11, Núm. 9, pp. 545-553

2003

  1. IL-1α (-889) promoter polymorphism is a risk factor for osteomyelitis

    American Journal of Medical Genetics, Vol. 119 A, Núm. 2, pp. 132-136